MedPath
NMPA Approval

Cefprozil for Suspension

国药准字H20133340

November 5, 2023

Drug Information

头孢丙烯干混悬剂

康赛哲

口服混悬剂

0.125g(按C18H19N3O5S计)

化学药品

November 5, 2023

Company Information

Applicant Company

洋浦经济开发区科技城生物制药园4号厂房

Manufacturing Company

海南洋浦经济开发区科技城生物制药园4号、5号厂房

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

头孢丙烯干混悬剂 - NMPA 批准文号 | MedPath